Board Meeting
Jaysynth Orgochem Schedules Board Meeting
Jaysynth Orgochem will hold a Board meeting on 13 November 2026 to consider unaudited standalone and consolidated financial results for the quarter and half year ended 30 September 2026.
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Investor Presentation
Q4 FY26
Investor Presentation
Q2 FY26
Investor Presentation
Q1 FY26
Jaysynth Orgochem Ltd (JDORGOCHEM) is currently trading at 15.39 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Jaysynth Orgochem Limited manufactures and trades colorants, dyes, pigments, digital ink dispersions and inkjet printers, operating manufacturing units at Taloja and Patalganga, and markets products under brands Reactofix and Terenix, with a consolidated structure that includes a wholly owned European subsidiary and a recently completed group restructuring effective May 2024. For FY26 the company reported consolidated total income of INR 26,271.31 lakhs and a consolidated profit after tax of INR 1,465.84 lakhs, reflecting roughly 10–11% revenue growth versus FY25 but a modest decline in PAT year‑on‑year, driven by higher deferred tax charges and working capital movements. The business is heavily skewed to the Colorants & Chemicals segment, which contributed the majority of revenue (over 80% of consolidated sales) while the Inkjet Printers vertical remains a smaller, loss‑making or marginal segment, highlighting concentrated exposure to dyes, pigments and digital ink products. Key corporate actions in the period include execution of the NCLT‑sanctioned Composite Scheme of Arrangement (effective May 2024), allotment of significant equity and preference shares to related entity shareholders, redemption of 6,00,00,000 preference shares during the year for INR 600 lakhs, and an unmodified auditor opinion for FY26 audited results. Management disclosed impacts from new labour codes leading to past service cost recognition and subsequent actuarial adjustments, with an actuarial liability now determined at INR 97.28 lakhs and a reversal of excess provision during FY26, reflecting accounting volatility from regulatory labour law changes.
Over the past 52 weeks, Jaysynth Orgochem Ltd has traded between a low of ₹9.57 and a high of ₹22.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Jaysynth Orgochem Ltd has a market capitalization of approximately 207.62. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Jaysynth Orgochem Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 11.26 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 207.62 Cr, Jaysynth Orgochem Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Jaysynth Orgochem Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Jaysynth Orgochem Ltd is 11.26. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The Board approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.
Chemicals & Petrochemicals
Specialty Chemicals
208 Cr
High Risk
11.3
33.9
0.1
1.6
22.00
9.57
Sales CAGR
Profit CAGR
ROE
ROCE
Upcoming Result Date: Nov 12, 2026
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Bearish
6
Neutral
2
Bullish
6
Bearish
7
Neutral
2
Bullish
37
Bearish
1
Neutral
0
Bullish
31
Bearish
1
Neutral
0
Bullish
31
Bearish
1
Neutral
0
Bullish
31
Bearish
1
Neutral
0
Bullish
31